Asante Capital congratulates partner Abingworth on the final closing of its new Clinical Co-Development Co-Investment Fund at $356 million
![](https://www.asantecapital.com/wp-content/uploads/2023/10/Abingworth-CCD-CIF-Closing-Image-1024x576.jpg)
We are delighted to share that Abingworth, a leading international life sciences investment group, part of global investment firm Carlyle (NASDAQ: CG), today announced the final closing of its new Clinical Co-Development Co-Investment Fund at $356 million.